Abstract

The University of Minnesota Cancer Center is dedicated to cancer research, education, and patient care for the citizens of the State of Minnesota and surrounding region. Our mission is to create a collaborative environment that advances knowledge about the causes, prevention, detection and treatment of cancer. The Cancer Center is """"""""comprehensive"""""""" in its breadth, encompassing population, basic and clinical and outreach studies. The Cancer Center is an """"""""administrative matrix"""""""" center with 98 nationally peer-reviewed and funded faculty Research Members. The center has five established research programs: Prevention and Etiology, Cancer Genetics, Cell Biology and Metastasis, Immunology and Transplant Biology and Therapy. The Center has six established shared resource cores. The Research Members are leading hypothesis-driven basic, translational, clinical and population based research of childhood and adult cancer. The University if Minnesota Cancer Center is unique to this region in the combination of (1) strong University-centered basic etiologic and experimental therapeutic research, and (2) extensive community (population) based studies of cancer susceptibility, prevention, early detection, behavior and nutrition.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA077598-02S1
Application #
2849542
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J1))
Program Officer
Vembu, Devi
Project Start
1998-06-01
Project End
2003-05-31
Budget Start
1999-06-01
Budget End
1999-06-02
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost

  Institution

Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455

  Publications

Scott, Milcah C; Temiz, Nuri A; Sarver, Anne E et al. (2018) Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma. Cancer Res 78:326-337
Guo, Zhijun; Johnson, Veronica; Barrera, Jaime et al. (2018) Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them. Cancer Metastasis Rev 37:409-423
Stabile, Laura P; Farooqui, Mariya; Kanterewicz, Beatriz et al. (2018) Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer. J Thorac Oncol 13:399-412
Ho, Yen-Yi; Nhu Vo, Tien; Chu, Haitao et al. (2018) A Bayesian hierarchical model for demand curve analysis. Stat Methods Med Res 27:2038-2049
Ustun, C; Brunstein, C; DeFor, T et al. (2018) Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation. Bone Marrow Transplant 53:97-100
How, Joan; Vij, Kiran R; Ebadi, Maryam et al. (2018) Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. Am J Hematol 93:E381-E383
Kaizer, Alexander M; Hobbs, Brian P; Koopmeiners, Joseph S (2018) A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics 74:1082-1094
Williams, Shelly M; Sumstad, Darin; Kadidlo, Diane et al. (2018) Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution. Transfusion 58:1458-1467
Li, Danni; Huang, Fangying; Zhao, Yingchun et al. (2018) Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study. Clin Proteomics 15:31
Sperduto, Paul W; Deegan, Brian J; Li, Jing et al. (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. Neuro Oncol 20:1652-1660

Showing the most recent 10 out of 1013 publications